Koers Breathtec Biomedical Inc Deutsche Boerse AG
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,6 mln. 2,4 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -6 mln. -5,53 mln. | Nettowinst (verlies) 2023 | -6 mln. -5,53 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,41 mln. 1,3 mln. | Nettoliquiditeiten 2023 | 125K 115K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,55
x | K/w-verhouding 2023 |
-0,37
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,2% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 01-03-18 |
James Kinley
DFI | Director of Finance/CFO | 45 | 01-12-21 |
Chief Operating Officer | 41 | 01-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 08-09-21 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 01-03-18 |
Mark Williams
BRD | Director/Board Member | 52 | 22-09-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 115 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-7,19% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,67% | 14,26 mld. | |
+33,90% | 12,37 mld. | |
-28,60% | 8,28 mld. |